Dr. Shane Needham PhD

Laboratory Director , Alturas Analytics Inc

What is a GLG Leader?|The Gerson Lehrman Group&reg; (GLG) Leader Program<sup>SM</sup> is our premium Member Program<sup>SM</sup>. Those identified as GLG Leaders are in the top 5% of GLG CouncilRank and have an exclusivity agreement with GLG.

GLG News by Dr. Shane Needham PhD, Laboratory Director

Analyses are solely the work of the authors and have not been edited or endorsed by GLG.

GLG News is now G+ Insights

G+ is a community for professionals, academics and entrepreneurs to connect through online discussions and in-person meetings. You will continue to see G+ Insights (formerly GLG News) here as well as on the G+ website, where you can share and discuss the G+ Insights you read.

New Mass Spectrometers Introduced and Current Use of "UPLC" from Recent American Society on Mass Spectrometry Conference

June 10, 2008

Recent American Society on Mass Spectrometry Conference June 1-5 2008 | www.asms.org

The recent ASMS conference show cased several vendors including Thermo, Waters and Agilent that introduced new triple quadrupole mass spectrometers that are meant to compete with the API4000 and API5000 from Applied Biosystems.  This could change the competitive landscape in the quantitative bioanalysis markets for triple quadrupole mass spectrometers. A workshop at the ASMS conference discussed the use of sub 2 um particles for HPLC/MS applications.  Waters calls this type of HPLC, "UPLC" however other vendors, Agilent, Shimadzu, Supelco (Sigma) have competing technologies.  This conference gave a great descriptive overview of the current practices in the pharmaceutical industry of sub 2 um HPLC.

Page : 11 to 1 of 1

Subscribe to Updates

RSS By RSS

Add to Google Reader or Homepage

Subscribe in Bloglines

Leading institutions connect with Shane Needham through GLG

Most Popular Healthcare News